Home / Leading CDMO Companies in APAC /
The APAC region has emerged as a powerhouse for Contract Development and Manufacturing Organizations (CDMOs) in the pharmaceutical industry. CDMOs in APAC offer a wide range of services, from drug development to large-scale commercial manufacturing, helping pharmaceutical and biotech companies worldwide bring innovative therapies to market efficiently.
CDMOs in APAC are known for their cutting-edge technology, world-class facilities, and competitive pricing. They specialize in handling various dosage forms, including oral solids, injectables, biologics, and complex formulations like lyophilized and sustained-release products. Many APAC CDMOs hold certifications from global regulatory bodies like EMA, FDA, and WHO, ensuring compliance across all phases—preclinical, clinical, and commercial.
APAC’s strategic location and well-developed infrastructure provide easy access to global markets, ensuring smooth logistics and rapid distribution. With a strong focus on innovation and R&D, APAC CDMOs are equipped to tackle even the most challenging pharmaceutical projects.
Drug Development: Expertise in formulation development, analytical testing, and process optimization to ensure stable and scalable pharmaceutical products.
Manufacturing: High-volume production across various formats, including oral solids, injectables, semi-solids, and biologics, ensuring flexible and high-quality solutions.
Regulatory Support: Assistance with regulatory filings and compliance for EMA, FDA, and global regulatory agencies to meet international market requirements.
Packaging Solutions: Comprehensive primary and secondary packaging services tailored to specific product needs, ensuring regulatory adherence and product safety.
Regulatory Expertise: CDMOs in APAC have a deep understanding of local, regional, and global regulatory standards, ensuring products meet stringent safety and efficacy benchmarks.
State-of-the-Art Facilities: APAC CDMOs are equipped with cutting-edge technologies, including aseptic and high-containment manufacturing capabilities, ensuring superior quality and efficiency.
Cost Efficiency: APAC CDMOs offer competitive pricing without compromising on product quality, making them a cost-effective solution for pharmaceutical companies.
Strategic Location: The APAC region’s well-developed logistics and distribution networks allow for efficient market access and timely product delivery worldwide.
Innovation and Sustainability: Many APAC CDMOs focus on continuous improvement, leveraging advanced technologies and sustainable practices for eco-friendly production solutions.
Some of the top CDMO companies in APAC:
Shilpa Biologicals: CDMO in APAC which support Process Development, Gene to Cell Line Development to GMP to Formulation Development, Analytical Development, Process Development, Drug Substance, Drug Product, Fill-Finish and Packaging. [See CDMO profile]
Pharmaron: Small molecules (RSM/APIs) and peptides manufacturing. [See CDMO profile]
Viswa Laboratories: CRAMS/CDMO, APIs, intermediates and specialty chemicals. [See CDMO profile]
Huiyu (Seacross) Pharma: CMO/CDMO services in APAC for global clients. [See CDMO profile]
Finding the right CDMO partner can be a complex task, but MAI CDMO is here to simplify the process. We connect you with pre-vetted CDMOs in the APAC region that align with your project requirements and goals. Our team of experts provides personalized support to ensure seamless collaboration and successful project outcomes.
Whether you need support in the early stages of drug development or require a reliable partner for large-scale commercial production, MAI CDMO offers unparalleled expertise and industry connections.
Contact us today to explore the best CDMO companies in APAC and start your pharmaceutical journey with a trusted partner.
If you have any questions or suggestions, click here. We will be happy to assist you.